Showing results (191-200 of 216) with videos related to

Sort By:
Pageof 22
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 28, 2024
Xelaglifam, a novel GPR40/FFAR1 agonist, exhibits enhanced β-arrestin recruitment and sustained glycemic control for type 2 diabetesJongmin Yoon, Don-Gil Lee, Haengjin Song, et al.
Breast Cancer Research and Treatment|January 2, 2010
The G12 family proteins upregulate matrix metalloproteinase-2 via p53 leading to human breast cell invasionEun-Sook Kim, Jae-Boon Jeong, Seonhoe Kim, et al.
Antioxidants & Redox Signaling|June 22, 2010
Ajoene, a stable garlic by-product, inhibits high fat diet-induced hepatic steatosis and oxidative injury through LKB1-dependent AMPK activationChang Yeob Han, Sung Hwan Ki, Young Woo Kim, et al.
British Journal of Pharmacology|July 10, 2024
Inhibition of dynamin-related protein 1-filamin interaction improves systemic glucose metabolismYuri Kato, Kohei Ariyoshi, Yasunobu Nohara, et al.
Pharmaceutics|February 26, 2025
Anti-Inflammatory and Pain-Relieving Effects of Arnica Extract Hydrogel Patch in Carrageenan-Induced Inflammation and Hot Plate Pain ModelsSang Gil Lee, Eun Byul Lee, Tack Soo Nam, et al.
International Journal of Cancer|May 26, 2020
UBC12-mediated SREBP-1 neddylation worsens metastatic tumor prognosisMi Jeong Heo, Sung Hyun Kang, Yun Seok Kim, et al.
Kidney International|April 25, 2014
Discovery of an integrative network of microRNAs and transcriptomics changes for acute kidney injuryChan Gyu Lee, Jin Geol Kim, Hyun Joo Kim, et al.
Cells|July 9, 2022
A TRPC3/6 Channel Inhibitor Promotes Arteriogenesis after Hind-Limb IschemiaTsukasa Shimauchi, Takuro Numaga-Tomita, Yuri Kato, et al.
Free Radical Biology & Medicine|January 26, 2010
The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosisDong-ha Shin, Hyun-Min Park, Kyeong-Ah Jung, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 13, 2024
Lower hepatotoxicity risk in Xelaglifam, a novel GPR40 agonist, compared to Fasiglifam for type 2 diabetes therapyJongmin Yoon, Haengjin Song, Ji Soo Park, et al.
Pageof 22